About the Company
We do not have any company description for Predictive Oncology Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Employees
4
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Predictive Oncology Inc.
POAI Stock Quote Price and Forecast | CNN
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal ...
Predictive Oncology Inc. Enters Standby Equity Purchase ... - Nasdaq
PITTSBURGH, July 08, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today that it has entered into a standby equity purchase ...
Predictive Oncology Inc
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal ...
Predictive Oncology Inc. Signs Letter of Intent to Acquire Quantitative ...
Predictive Oncology’s Helomics division has built an AI knowledgebase of drug response profiles from over 150,000 cancer cases, Using AI to leverage that data the information can now be ...
Predictive Oncology Inc. Launches Website Showcasing AI-Driven ...
About Predictive Oncology Inc. Predictive Oncology is a knowledge-driven company focused on applying artificial intelligence (“AI”) to develop personalized cancer therapies, which can lead to ...
Predictive Oncology Inc. (POAI) Stock Price Today - WSJ
View the latest Predictive Oncology Inc. (POAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Predictive Oncology Inc. (POAI) Q3 2022 Earnings Call Transcript
10-Q EPS of -$1.00 misses by $1.00 Predictive Oncology Inc. (NASDAQ:POAI) Q3 2022 Earnings Conference Call November 11, 2022 12:00 PM ET Company Participants Theresa Ferguson - Investor Relations ...
Predictive Oncology Inc. Announces Newest Board Member
In 2015, Mr. Vennare was appointed Chief Executive Officer and Chairman of the Board of Cvergenx, Inc., a genomic informatics company developing decision-support tools for radiation oncology.
Predictive Oncology Announces DojoLIVE! Interview with Helomics CIO ...
LOS ANGELES, Aug. 14, 2020 (GLOBE NEWSWIRE) -- via NetworkWire — Predictive Oncology Inc. (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to ...
POAI - Predictive Oncology Inc Ownership | Morningstar
Review which funds and institutions currently hold Predictive Oncology Inc (POAI:XNAS) stock for ownership information.
Predictive Oncology Inc.: Predictive Oncology Reports Second Quarter ...
Predictive Oncology recorded revenue of $490,110 in the second quarter of 2023, compared to $371,591 in 2022. Sales of Streamway related products and services by our Eagan operating segment were ...
Predictive Oncology Inc. (POAI) CEO Carl Schwartz on Q2 2019 Results ...
Predictive Oncology Inc. (NASDAQ:POAI) Q2 2019 Results Earnings Conference Call August 19, 2019 5:30 PM ET Company Participants Scott Gordon - IR, CORE IR Carl Schwartz - President and CEO ...
Similar Companies
Loading the latest forecasts...